Stephen Harkins, DDS
Oral and Maxillofacial Surgery · Tucson, AZNPI 1477599827
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 31.9% of the total. Reporting peaked in 2023 at $491 and has fallen 63.5% since, to $179 in 2025.
Across 63 payments — averaging $28.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$580
- Novartis$215
- Teva Pharmaceuticals USA, Inc.$201
- Pfizer$160
- Biohaven Pharmaceuticals, Inc.$158
- Watermark Medical, Inc.$101
- plus $406 from 9 others
What the payments were for
- Food & beverage$1,820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $580 |
| Novartis | 10 | $215 |
| Teva Pharmaceuticals USA, Inc. | 9 | $201 |
| Pfizer | 10 | $160 |
| Biohaven Pharmaceuticals, Inc. | 3 | $158 |
| Watermark Medical, Inc. | 1 | $101 |
| Lundbeck LLC | 5 | $95 |
| Amgen | 4 | $80 |
| Lilly USA, LLC | 4 | $64 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Upsher-smith Laboratories LLC | 2 | $37 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Merz Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$225
- QULIPTA$221
- NURTEC ODT$121
- ARES HOME SLEEP TESTING DEVICE$101
How this compares
$1,820 in reported general payments places this provider in the 60th percentile of 147 oral and maxillofacial surgery providers in Arizona.
See all oral and maxillofacial surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 52 | $723 |
| Doxepin Hcl | 30 | $636 |
| Tizanidine Hcl | 51 | $568 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Tucson
- Nicholas ColesTucson$26K
- Robert WoodTucson$18K
- Negin SaghafiTucson$17K
- Justin OrtonTucson$15K
- John SchmidtTucson$8K
- Cesar RiveraTucson$8K
- Kelton EricsonTucson$4K
- Daniel KlemmedsonTucson$2K
- Caroline KacerTucson$2K
- Brent BoyseMesa$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.